EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and in vitro models identify distinct adaptations enhancing Staphylococcus aureus pathogenesis in human macrophages

Dustin R Long, Elizabeth A Holmes, Hsin-Yu Lo, Kelsi Penewit, Jared Almazan, Taylor Hodgson, Nova F Berger, Zoe H Bishop, Janessa D Lewis, Adam Waalkes, Daniel J Wolter, Stephen J Salipante iD

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Dustin R Long und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Critical Care Medicine, Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, Washington,…. Hauptthemen laut MEDLINE: Staphylococcus aureus, Macrophages, Staphylococcal Infections, Genome-Wide Association Study. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, Vertex Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus aureus is a facultative intracellular pathogen of human macrophages, which facilitates chronic infection. The genotypes, pathways, and mutations influencing that phenotype remain incompletely explored. Here, we used two distinct strategies to ascertain S . aureus gene mutations affecting pathogenesis in macrophages. First, we analyzed isolates collected serially from chronic cystic fibrosis (CF) respiratory infections. We found that S . aureus strains evolved greater macrophage invasion capacity during chronic human infection. Bacterial genome-wide association studies (GWAS) identified 127 candidate genes for which mutation was significantly associated with macrophage pathogenesis in vivo . In parallel, we passaged laboratory S . aureus strains in vitro to select for increased infection of human THP-1 derived macrophages, which identified 15 candidate genes by whole-genome sequencing. Functional validation of candidate genes using isogenic transposon mutant knockouts and CRISPR interference (CRISPRi) knockdowns confirmed virulence contributions from 37 of 39 tested genes (95%) implicated by in vivo studies and 7 of 10 genes (70%) ascertained from in vitro selection, with one gene in common to the two strategies. Validated genes included 17 known virulence factors (39%) and 27 newly identified by our study (61%), some encoding functions not previously associated with macrophage pathogenesis. Most genes (80%) positively impacted macrophage invasion when disrupted, consistent with the phenotype readily arising from loss-of-function mutations in vivo . This work reveals genes and mechanisms that contribute to S . aureus infection of macrophages, highlights differences in mutations underlying convergent phenotypes arising from in vivo and in vitro systems, and supports the relevance of S . aureus macrophage pathogenesis during chronic respiratory infection in CF. Additional studies will be needed to illuminate the exact mechanisms by which implicated mutations affect their phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusMacrophagesStaphylococcal InfectionsGenome-Wide Association StudyCystic FibrosisHumansMutationVirulenceVirulence FactorsAdaptation, Physiological

Substanzen

Virulence Factors

Autor:innen und Institutionen

  • Division of Critical Care Medicine, Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America.
  • Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
  • Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, United States of America.

ORCID-Profile: Stephen J Salipante

Förderung

  • NIAMS NIH HHS
  • NIDDK NIH HHS
  • Vertex Pharmaceuticals
  • Cystic Fibrosis Foundation
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Long, D. R., Holmes, E. A., Lo, H. Y., Penewit, K., Almazan, J., Hodgson, T., Berger, N. F., Bishop, Z. H., Lewis, J. D., Waalkes, A., Wolter, D. J., & Salipante, S. J. (2024). Clinical and in vitro models identify distinct adaptations enhancing Staphylococcus aureus pathogenesis in human macrophages. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012394

Vancouver

Long DR, Holmes EA, Lo HY, Penewit K, Almazan J, Hodgson T, et al. Clinical and in vitro models identify distinct adaptations enhancing Staphylococcus aureus pathogenesis in human macrophages. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012394

BibTeX
@article{Long2024,
  author = {Long, Dustin R and Holmes, Elizabeth A and Lo, Hsin-Yu and Penewit, Kelsi and Almazan, Jared and Hodgson, Taylor and Berger, Nova F and Bishop, Zoe H and Lewis, Janessa D and Waalkes, Adam and Wolter, Daniel J and Salipante, Stephen J},
  title = {Clinical and in vitro models identify distinct adaptations enhancing Staphylococcus aureus pathogenesis in human macrophages},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012394}
}
Kostenlos starten →